Blog
A quantitative systems pharmacology workflow towards optimal design and biomarker stratification of atopic dermatitis clinical trials
A quantitative techniques pharmacology workflow in the direction of optimum design and ...
Berotralstat Prophylaxis Reduces HAE Attack Rates Regardless of Baseline Attacks: Real-World Outcomes
Berotralstat, a once-daily oral prophylactic remedy for hereditary angioedema (HAE), ...
Role of an embedded health system specialty pharmacy on prescription of biologics in allergy/immunology
Since 2015, there was a considerable enhance in biologics to handle atopic circumstances. ...
Dupilumab-induced Conjunctivitis In Atopic Dermatitis Patients Is Associated To An Increase Of Proinflammatory Molecules In Tears.
Dupilumab (DU) is an efficient therapy in each atopic dermatitis (AD) and T2 bronchial ...
Utilizing Machine Learning with Claims Data to Diagnose and Quantify the Prevalence of Eosinophilic Granulomatosis with Polyangiitis
Eosinophilic granulomatosis with polyangiitis (EGPA) is a vasculitis that may current ...
Population Pharmacokinetic/Pharmacodynamic Analysis Of Garadacimab, In Patients With Hereditary Angioedema
Garadacimab (anti-activated issue XII monoclonal antibody) is being evaluated for ...
Basophil-dependent induction of Galectin-3 in human monocytes
Now we have beforehand proven that human basophils launch mediators (histamine, IL-4, ...
Remibrutinib Treatment Has No Impact on Blood Counts in Patients With Chronic Spontaneous Urticaria: Results From Phase 2b 52-week Extension Study Results
Remibrutinib (LOU064), a extremely selective oral Bruton’s tyrosine kinase inhibitor, has ...
- « Previous Page
- 1
- …
- 80
- 81
- 82
- 83
- 84
- …
- 104
- Next Page »
